$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
2992治疗肺癌效果好吗?
2025-10-19 11:44:20
Check Details
易瑞沙医保报销后多少钱?
2025-10-19 11:44:20
Check Details
2992耐药时间
2025-10-19 11:44:20
Check Details
2992一盒价格多少?
2025-10-19 11:44:20
Check Details
恩曲替尼在欧洲获批两个适应症:用于NTRK融合实体瘤和ROS1阳性非小细胞肺癌
2025-10-19 11:44:20
Check Details
易瑞沙医保可以报销多少?
2025-10-19 11:44:20
Check Details
易瑞沙治疗肺癌患者疗效如何?
2025-10-19 11:44:20
Check Details
肺癌靶向药2992
2025-10-19 11:44:20
Check Details
易瑞沙目前已知获批适应症有什么?
2025-10-19 11:44:20
Check Details
靶向药2992价格多少?
2025-10-19 11:44:20
Check Details
2992(阿法替尼,吉泰瑞)价格多少?
2025-10-19 11:44:20
Check Details
易瑞沙主要用于治疗什么病症呢?
2025-10-19 11:44:20
Check Details
1
2
...
9572
9573
9574
9575
9576
9577
9578
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Urece® (Dotinurad): A Breakthrough in Gout and Hyperuricemia Management
2
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
3
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
4
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
5
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
6
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
7
A Precision FGFR Inhibitor for Cholangiocarcinoma
8
A Revolutionary Targeted Therapy for Hematological Malignancies
9
A New Option for Advanced Renal Cell Carcinoma Treatment
10
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
11
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
12
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial